Tripterygium Wilfordii Hook F and Methotrexate for Postmenopausal Women With Rheumatoid Arthritis
Status:
Recruiting
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
This study is a multicenter, randomized, double-blinded, controlled trial with two parallel
arms. The aim of the study is to evaluate whether Tripterygium wilfordii Hook F combined with
methotrexate (MTX) might be better than MTX alone for postmenopausal women with active
rheumatoid arthritis (RA).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences